skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycooctaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > globoside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > globoside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > globoside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > globoside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide
organooxygen compound > sphingolipid > glycosphingolipid > globoside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide

اصطلاح مرجح

alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-(alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4))-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • 0

فرمول

  • C58H96N4O42R2

جرم

  • 1521.387

جرم تک‌ایزوتوپی

  • 1520.54991

اسمایلٓ

  • [C@@H]1([C@H](O[C@@H](O[C@@H]2[C@H]([C@@H](O[C@H]3[C@H](O[C@@H](O[C@@H]4[C@H](O[C@@H](OC[C@@H]([C@@H](*)O)NC(=O)*)[C@@H]([C@H]4O)O)CO)[C@@H]([C@H]3O)O)CO)O[C@@H]([C@@H]2O[C@@H]5O[C@@H]([C@H](O)[C@@H]([C@H]5NC(C)=O)O[C@H]6[C@@H]([C@H]([C@@H](O)[C@H](O6)CO)O)O[C@H]7[C@H]([C@@H]([C@@H]([C@@H](O7)C)O)O)O)CO)CO)O)[C@@H]([C@H]1O[C@@H]8[C@@H]([C@H]([C@@H](O)[C@H](O8)CO)O)NC(C)=O)NC(C)=O)CO)O

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141192

این مفهوم را بارگیری کن: